SGLT2-inhibitors are effective and safe in the elderly: The SOLD study

医学 恩帕吉菲 达帕格列嗪 卡格列净 内科学 糖尿病 肾功能 糖化血红素 不利影响 人口 危险系数 二甲双胍 2型糖尿病 体质指数 胰岛素 置信区间 内分泌学 环境卫生
作者
Maria Elena Lunati,Vincenzo Cimino,Alessandra Gandolfi,Matteo Trevisan,Laura Montefusco,Ida Pastore,Camilla Pace,Nazarena Betella,Giuseppe Favacchio,Monica Bulgheroni,Loredana Bucciarelli,Giulia Massari,Cristina Mascardi,Angela Girelli,Paola Silvia Morpurgo,Franco Folli,Livio Luzi,Marco Mirani,Basilio Pintaudi,Federico Bertuzzi,Cesare Berra,Paolo Fiorina
出处
期刊:Pharmacological Research [Elsevier]
卷期号:183: 106396-106396 被引量:22
标识
DOI:10.1016/j.phrs.2022.106396
摘要

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) may have important benefits for the elderly with type 2 diabetes (T2D), however some safety concerns still limit their use in patients over 70 years of age. The SOLD study (SGLT2i in Older Diabetic patients) is a multicenter study, aimed to evaluate the effectiveness and safety of SGLT2i in the older diabetic patients in a real-life setting. We analyzed a population of 739 adults (mean age 75.4 ± 3.9 years, M/F 420/319) with T2D, which started a SGLT2i-based treatment after the age of 70, with at least one year of follow-up. Data were collected at baseline, at 6 and 12 months of follow-up. SGLT2i (37.5% Empagliflozin, 35.7% Dapagliflozin, 26.1% Canagliflozin, 0.7% Ertugliflozin) were an add-on therapy to Metformin in 88.6%, to basal insulin in 36.1% and to other antidiabetic drugs in 29.6% of cases. 565 subjects completed the follow up, while 174 (23.5%) discontinued treatment due to adverse events which were SGLT2i related. A statistically significant reduction of glycated hemoglobin (baseline vs 12 months: 7.8 ± 1.1 vs 7.1 ± 0.8%, p < 0.001) and body mass index values (baseline vs 12 months: 29.2 ± 4.7 vs 28.1 ± 4.5 kg/m2, p < 0.001) were evident during follow-up. Overall, estimated glomerular filtration rate remained stable over time, with significant reduction of urinary albumin excretion. In the subgroup of patients which were ≥ 80 years, a significant improvement in glycated hemoglobin values without renal function alterations was evident. Overall discontinuation rate during the follow-up period was different across age groups, being urinary tract infections and worsening of renal function the most common cause. SGLT2i are well-tolerated and safe in the elderly and appear as an effective therapeutic option, though some caution is also suggested, especially in more fragile subjects.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
金子完成签到,获得积分20
刚刚
1秒前
1秒前
Jewel完成签到,获得积分20
2秒前
Xiaoyang发布了新的文献求助10
3秒前
1257应助科研通管家采纳,获得20
3秒前
星辰大海应助科研通管家采纳,获得10
3秒前
3秒前
领导范儿应助科研通管家采纳,获得10
3秒前
abbyi完成签到,获得积分10
3秒前
1257应助科研通管家采纳,获得10
3秒前
充电宝应助科研通管家采纳,获得10
3秒前
1257应助科研通管家采纳,获得10
3秒前
3秒前
隐形曼青应助科研通管家采纳,获得10
4秒前
汉堡包应助科研通管家采纳,获得10
4秒前
4秒前
4秒前
星辰大海应助l玖采纳,获得10
4秒前
Lhz完成签到,获得积分10
4秒前
5秒前
5秒前
yier发布了新的文献求助10
5秒前
赘婿应助无奈满天采纳,获得10
6秒前
李哈哈发布了新的文献求助10
6秒前
田様应助tty采纳,获得10
6秒前
小二郎应助湖里采纳,获得10
6秒前
7秒前
Huang发布了新的文献求助10
7秒前
7秒前
英俊枫完成签到,获得积分10
7秒前
8秒前
tyl完成签到 ,获得积分20
8秒前
8秒前
四不像会麋鹿完成签到,获得积分10
8秒前
9秒前
雪白的面包完成签到 ,获得积分10
9秒前
Jewel发布了新的文献求助20
9秒前
奎尼丁发布了新的文献求助10
9秒前
Xiaoyang完成签到,获得积分10
9秒前
高分求助中
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Gerard de Lairesse : an artist between stage and studio 500
Digging and Dealing in Eighteenth-Century Rome 500
Queer Politics in Times of New Authoritarianisms: Popular Culture in South Asia 500
Livre et militantisme : La Cité éditeur 1958-1967 500
Retention of title in secured transactions law from a creditor's perspective: A comparative analysis of selected (non-)functional approaches 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3063975
求助须知:如何正确求助?哪些是违规求助? 2718618
关于积分的说明 7461287
捐赠科研通 2365090
什么是DOI,文献DOI怎么找? 1253884
科研通“疑难数据库(出版商)”最低求助积分说明 608721
版权声明 596643